• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Anika Therapeutics Inc

+ Add to Watchlist


39.6000 USD 0.00000.00%

As of 20:10:00 ET on 01/23/2015.

Snapshot for Anika Therapeutics Inc (ANIK)

Open: 39.6700 Day's Range: 38.8700 - 39.9450 Volume: 155,124
Previous Close: 39.6000 52wk Range: 28.7900 - 52.4900 1-Yr Rtn: +14.92%

Stock Chart for ANIK

No chart data available.
  • ANIK:US 39.6000
  • 1D
  • 1M
  • 1Y
Interactive ANIK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ANIK

Current P/E Ratio (ttm) 16.3858
Estimated P/E(12/2014) 15.8084
Relative P/E vs. SPX 0.8996
Earnings Per Share (USD) (ttm) 2.4167
Est. EPS (USD) (12/2014) 2.5050
Est. PEG Ratio 0.5269
Market Cap (M USD) 574.36
Shares Outstanding (M) 14.50
30 Day Average Volume 160,138
Price/Book (mrq) 3.4536
Price/Sale (ttm) 5.5586
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ANIK

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ANIK

Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products and devices. The Company's products, based on hyaluronic acid, promote the repair, protection, and healing of bone, cartilage, and soft tissue. Anika's products include ORTHOVISC and HYVISC which treat osteoarthritis.

Charles H SherwoodPresident/CEOSylvia CheungCFO/Treasurer/Secretary
Frank J LuppinoChief Operating OfficerEdward S AhnChief Technology & Strategy Ofcr
More Company Profile & Key Executives for ANIK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil